Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL

Abstract Introduction Although quality of life (QoL) is recognized as an important indicator of the course of a disease, it has rarely been addressed in studies evaluating the outcome of care for patients with pulmonary embolism (PE). This study primarily aimed to evaluate the QoL of patients with a...

Full description

Saved in:
Bibliographic Details
Published in:Thrombosis research 2013-11, Vol.132 (5), p.500-505
Main Authors: van Es, Josien, den Exter, Paul L, Kaptein, Ad A, Andela, Cornelie D, Erkens, Petra M.G, Klok, Frederikus A, Douma, Renee A, Mos, Inge C.M, Cohn, Danny M, Kamphuisen, Pieter W, Huisman, Menno V, Middeldorp, Saskia
Format: Article
Language:English
Subjects:
Acute Disease
Aged
Female
Hematology, Oncology and Palliative Medicine
Humans
Male
Middle Aged
Outpatients
PEmb-QoL
Pulmonary embolism
Pulmonary Embolism - diagnosis
Pulmonary Embolism - therapy
Qanadli score
Quality of Life
SF-36
Surveys and Questionnaires
Venous thrombo-embolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Introduction Although quality of life (QoL) is recognized as an important indicator of the course of a disease, it has rarely been addressed in studies evaluating the outcome of care for patients with pulmonary embolism (PE). This study primarily aimed to evaluate the QoL of patients with acute PE in comparison to population norms and to patients with other cardiopulmonary diseases, using a generic QoL questionnaire. Secondary, the impact of time period from diagnosis and clinical patient characteristics on QoL was assessed, using a disease-specific questionnaire. Methods QoL was assessed in 109 consecutive out-patients with a history of objectively confirmed acute PE (mean age 60.4 ± 15.0 years, 56 females), using the generic Short Form-36 (SF-36) and the disease specific Pulmonary Embolism Quality of Life questionnaire (PEmb-QoL). The score of the SF-36 were compared with scores of the general Dutch population and reference populations with chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), a history of acute myocardial infarction (AMI), derived from the literature. Scores on the SF-35 and PEmb-QoL were used to evaluate QoL in the short-term and long-term clinical course of patients with acute PE. In addition, we examined correlations between PEmb-QoL scores and clinical patient characteristics. Results Compared to scores of the general Dutch population, scores of PE patients were worse on several subscales of the SF-36 (social functioning, role emotional, general health (P < 0.001), role physical and vitality (P < 0.05)). Compared to patients with COPD and CHF, patients with PE scored higher (= better) on all subscales of the SF-36 (P ≤ 0.004) and had scores comparable with patients with AMI the previous year. Comparing intermediately assessed QoL with QoL assessed in long-term follow-up, PE patients scored worse on SF-36 subscales: physical functioning, social functioning, vitality (P < 0.05), and on the PEmb-QoL subscales: emotional complaints and limitations in ADL (P ≤ 0.03). Clinical characteristics did not correlate with QoL as measured by PEmb-QoL. Conclusion Our study demonstrated an impaired QoL in patients after treatment of PE. The results of this study provided more knowledge about QoL in patients treated for PE.
ISSN:0049-3848
1879-2472
DOI:10.1016/j.thromres.2013.06.016